Catalyst Wire Dossier Catalyst Wire Dossier

Partially Hydrolysed Protein Infant Formula

· Société des Produits Nestlé (SPN)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Partially Hydrolysed Protein Infant Formula, covering 2025-06-27 to 2025-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL) [NA]

See pricing